National Institutes of Health: Pancreatic Neoplasms trials
The registry lists 117 Pancreatic Neoplasms studies with National Institutes of Health as lead sponsor. 14 are open to participants now and 37 have results posted.
Early Phase 1 1Phase 1 59Phase 2 62Phase 3 2No phase 8(a study in two phases counts in both)
Studies
Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
- Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic CancerCompletedNCT00028834Phase 2
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerCompletedNCT00028496Phase 1
- Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT00026104Phase 2
- Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the PancreasCompletedNCT00020345Phase 2
- Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasCompletedNCT00019513Phase 1
- LMB-9 Immunotoxin in Treating Patients With Advanced Solid TumorsCompletedNCT00019435Phase 1
- Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsCompletedNCT00019331Phase 2
- Vaccine Therapy and Biological Therapy in Treating Patients With Advanced CancerCompletedNCT00019084Phase 2
- Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung CancerCompletedNCT00019006Phase 1
- Immunotoxin Therapy in Treating Patients With Advanced CancerCompletedNCT00006981Phase 1
- Gemcitabine, Herceptin and Radiation to Treat Cancer of the PancreasCompletedNCT00005926Phase 2
- R115777 in Treating Patients Who Have Metastatic Pancreatic CancerCompletedNCT00005843Phase 2
- Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
- A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by RituximabCompletedNCT00001805Phase 2
- A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the PancreasCompletedNCT00001431Phase 1